Generex Biotechnology to Make Presentations At 46th Annual Meeting
of the European Society of Pediatric Endocrinology
WORCESTER, Mass., Jun 27, 2007 (PrimeNewswire via COMTEX NewsNetwork) --
Generex Biotechnology Corporation (Nasdaq:GNBT), theleader in drug delivery for metabolic diseases through the innerlining of the mouth, announced today that it will be making threeposter presentations at the 46th Annual Meeting of the EuropeanSociety of Pediatric Endocrinology in Helsinki, Finland June 27 --30, 200...
Generex Biotechnology Vaccine Strategy Presented at International
Conference in London
WORCESTER, MA - May 24, 2007 -
Generex Biotechnology Corporation(NasdaqCM:GNBT) announced today that Dr. Douglas Powell, Directorof Immunobiology at its wholly-owned Antigen Express subsidiary,has presented Antigen's vaccine development strategy at aninternational conference in London, UK. The international meeting,"Developing New Anti-Infective Agents - Challenges andOpportunities" (<a...